Skip to main content

Hudson Bay Capital Management LP

Position in NKTR — Nektar Therapeutics

CIK 1393825 STAMFORD, CT

Position in NKTR

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$743,387
-$1,780,348 QoQ
Shares Held
10,332
-82.7% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Derivatives in NKTR

reported options exposure · as of Mar 31, 2022
CallValue
$269,500
CallShares
3,333
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Hudson Bay Capital Management LP holds $565,820,903 across 77 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in NKTR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $743,387 10,332
2025-12-31 $2,523,735 59,691
2025-09-30 $6,126,877 107,678
2022-03-31 $269,500 50,000
2021-12-31 $406,651 30,100
2021-12-31 $945,700 70,000
2021-09-30 $1,661,300 92,500
2021-06-30 $1,887,600 110,000
2021-03-31 $1,500,000 75,000
2020-12-31 $1,360,000 80,000
2020-09-30 $2,073,750 125,000
2020-06-30 $2,740,221 118,317
2020-03-31 $2,320,500 130,000